ESC Professional Premium Access

Epidemiology, prognosis, course, and outcome of valvular heart disease

Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Date: 29 August 2022
Time: 12:15 - 12:55

Congress Session

6 presentations in this session

Tricuspid regurgitation: frequency, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP valvular heart disease II survey

Speaker: Doctor J. Dreyfus (Saint Denis, FR)
Thumbnail

Outcomes benefit in asymptomatic patients with moderate aortic valve stenosis followed up in heart valve clinics

Speaker: Doctor P. Paolisso (Aalst, BE)
Thumbnail

Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis

Speaker: Associate Professor A. Coisne (Lille, FR)
Thumbnail

Heritability and environmental influences on the onset of aortic valve sclerosis: a twin population study

Speaker: Doctor P. Poggio (Milan, IT)
Thumbnail

The long-term clinical course of moderate tricuspid regurgitation

Speaker: Doctor D. Margonato (Milan, IT)
Thumbnail

Modeling aortic stenosis progression: impact on follow-up, treatment and survival

Speaker: Doctor R. Teixeira (Vila Nova de Gaia, PT)
Thumbnail

6 speakers from this session

Doctor Julien Dreyfus

Centre Cardiologique du Nord (CCN), Saint Denis (France)
1 presentation
0 follower

Doctor Pasquale Paolisso

Cardiovascular Research Center Aalst, Aalst (Belgium)
0 follower

Associate Professor Augustin Coisne

Lille University Hospital, Lille (France)
13 presentations
0 follower

Doctor Paolo Poggio

Monzino Cardiology Centre, Milan (Italy)
0 follower

Doctor Davide Margonato

IRCCS San Raffaele Hospital, Milan (Italy)
0 follower

Doctor Rafael Teixeira

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)
0 follower

This platform is supported by

logo Novo Nordisk